MCT8 Deficiency in Females
The Journal of Clinical Endocrinology & Metabolism · 18.12.2025 · 111 (1) · e175-e184
DOI: 10.1210/clinem/dgaf311 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 27.05.2025. Verfasst von Stefan Groeneweg und 28 weiteren Autor:innen. Beteiligte Einrichtung: Academic Center for Thyroid Diseases, Department of Internal Medicine, Erasmus Medical Center, Erasmus University Rotterdam, 3015 GD Rotterdam, the N…. Hauptthemen laut MEDLINE: Monocarboxylic Acid Transporters, Muscle Hypotonia, X-Linked Intellectual Disability, Muscular Atrophy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Netherlands Organisation for Health Research and Development, Sherman Foundation, Eurostars program.
Abstract (Originalsprache)
Context
Monocarboxylate transporter (MCT) 8 facilitates thyroid hormone (TH) transport across the blood-brain barrier. Pathogenic variants in SLC16A2 cause MCT8 deficiency (Allan-Herndon-Dudley syndrome), characterized by intellectual and motor disability and abnormal thyroid function tests. MCT8 deficiency typically affects males due to its X-linked inheritance.
Objective
Here, we report 8 female patients with heterozygous pathogenic variants in SLC16A2 who presented with variable neurocognitive impairment, behavioral problems, and TH function abnormalities.
Methods
We performed X-chromosome inactivation studies in female patients in whom heterozygous pathogenic variants in SLC16A2 were identified. The effect of SLC16A2 variants on TH transport was assessed in transfected cells and patient-derived fibroblasts.
Results
In all patients (mean age 8.6 years; range, 2.3-25 years) routine care genetic analyses identified heterozygous variants in SLC16A2 (p.(R445C), p.(N193I), p.(G276R), t(X;20), resulting in a breakpoint in intron 1, t(X;19), resulting in a breakpoint in SLC16A2, p.(I562Sfs566*), p.(G221R)). All missense variants showed substantially reduced MCT8-mediated TH uptake in transiently transfected cells. X-chromosome inactivation studies in patient cells showed skewed X-inactivation in all 7 evaluated individuals. In 5 out of 7 evaluated cases, MCT8-mediated 3,5,3′-triiodothyronine (T3) uptake in patient-derived fibroblasts was impaired to a similar degree as in fibroblasts derived from male patients with MCT8 deficiency.
Conclusion
Female patients with heterozygous pathogenic variants in SLC16A2 and skewed X-chromosome inactivation may present with variable neuro(psycho)logical, behavioral, and thyroid function test abnormalities. Female patients presenting with neurocognitive impairment and abnormal TH function tests (low free thyroxine and/or high total T3 concentrations) should be tested for genetic variants in SLC16A2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Academic Center for Thyroid Diseases, Department of Internal Medicine, Erasmus Medical Center, Erasmus University Rotterdam, 3015 GD Rotterdam, the Netherlands.
- Department of Paediatric Neurology, Universitäts-Kinderspital Zürich, 8008 Zurich, Switzerland.
- Unit of Child Neuropsychiatry, Department of Neurosciences, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
- The Thyroid Center, Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
- Department of Paediatrics, The University of Pennsylvania, Philadelphia, PA 19104, USA.
- Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
ORCID-Profile: Stefan Groeneweg, Ferdy S van Geest, Floor van der Most, Lucia Abela, Paolo Alfieri, Enrico Bertini, Marco Cappa, Nurullah Çelik, Irenaeus F M de Coo, Ilja Dubinski, Jorge L Granadillo, Lies H Hoefsloot, Vera M Kalscheuer, Marieke M van der Knoop, Heiko Krude, Robin P Peeters, Markus Schuelke, Ulrich Schweizer, Jennifer E Sprague, A S Paul van Trotsenburg, Nina-Maria Wilpert, Ginevra Zanni, Laura J C M van Zutven, W Edward Visser
Förderung
- Netherlands Organisation for Health Research and Development
- Sherman Foundation
- Eurostars program
Zitieren
APA
Groeneweg, S., van Geest, F. S., van der Most, F., Abela, L., Alfieri, P., Bauer, A. J., Bertini, E., Cappa, M., Çelik, N., de Coo, I. F. M., Dolcetta-Capuzzo, A., Dubinski, I., Granadillo, J. L., Hoefsloot, L. H., Kalscheuer, V. M., van der Knoop, M. M., Krude, H., McNerney, K. P., Paone, L., …, & Visser, W. E. (2025). MCT8 Deficiency in Females. The Journal of Clinical Endocrinology & Metabolism, 111(1), e175-e184. https://doi.org/10.1210/clinem/dgaf311
Vancouver
Groeneweg S, van Geest FS, van der Most F, Abela L, Alfieri P, Bauer AJ, et al. MCT8 Deficiency in Females. The Journal of Clinical Endocrinology & Metabolism. 2025;111(1):e175-e184. doi:10.1210/clinem/dgaf311
BibTeX
@article{Groeneweg2025,
author = {Groeneweg, Stefan and van Geest, Ferdy S and van der Most, Floor and Abela, Lucia and Alfieri, Paolo and Bauer, Andrew J and Bertini, Enrico and Cappa, Marco and Çelik, Nurullah and de Coo, Irenaeus F M and Dolcetta-Capuzzo, Anna and Dubinski, Ilja and Granadillo, Jorge L and Hoefsloot, Lies H and Kalscheuer, Vera M and van der Knoop, Marieke M and Krude, Heiko and McNerney, Kyle P and Paone, Laura and Peeters, Robin P and Peters, Catherine and Schuelke, Markus and Schweizer, Ulrich and Sprague, Jennifer E and van Trotsenburg, A S Paul and Wilpert, Nina-Maria and Zanni, Ginevra and van Zutven, Laura J C M and Visser, W Edward},
title = {MCT8 Deficiency in Females},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {111},
number = {1},
pages = {e175--e184},
doi = {10.1210/clinem/dgaf311}
}
EUVIMED